menting these descriptions, we report a prospective longitudinal study of change in urine fentanyl prevalence in a highrisk, community-based sample. 5 Methods | Directly assessed participants were from a health outcomes study of people living in an impoverished neighborhood of Vancouver, Canada. 5 For context, overall overdose deaths (Vancouver) and first responder calls (Vancouver and neighborhood-specific) were obtained from the British Columbia Coroner's Office and Vancouver Police and Fire statistics for the study period (March 1 to July 31, 2017). Participants attended monthly visits and reported prescribed and nonprescribed drug use during the previous week, including fentanyl, buprenorphine, codeine, heroin, hydromorphone, methadone, morphine, and oxycodone. Participants (N = 237) contributed 595 urine samples that were tested for fentanyl/norfentanyl, opiates (morphine, heroin, and codeine), and methadone using detection strips (BTNX Inc). Agreement between reports and detection was assessed by κ statistic. Repeated measures logistic mixed- The British Columbia Coroner's Office reports of overdose deaths in Vancouver and overdose calls to first responders (police and fire department) for Vancouver and for the neighborhood from which participants were recruited (A). Numbers of urine samples with fentanyl detected are shown for participants using nonprescribed opioids and for those taking prescribed opioid agonist therapy (B). The probability of urine samples being positive for fentanyl (C) or opiates (heroin, morphine, or codeine) (D) changed during a 5-month period and differed according to reported use of nonprescribed opioids in the week before urinalysis. Samples were tested for fentanyl/norfentanyl (sensitivity 10 ng/mL, with cross-reactivity for acetylfentanyl, butyrylfentanyl, carfentanil, fluorofentanyl, 4-fluoroisobutyryl fentanyl, furanylfentanyl, 3-methylfentanyl, sufentanil, and thiofentanyl) and for opiates (heroin, morphine, and codeine). Shading represents the 95% confidence interval.
effects models with random intercept and slope were used to estimate associations between detection and reported opioid use in the prior week. Fixed effects of recent nonprescribed opioid use over time were estimated adjusting for age and sex. The study was approved by the institutional review boards at the University of British Columbia and Simon Fraser University, and participants provided written informed consent. Table) . With self-reported nonprescribed opioid use, fentanyl detection probability was greater (odds ratio, 34.47; P < .001) and increased at a faster rate over time (odds ratio, 2.34; P = .03). In contrast, opiate detection decreased over time (odds ratio, 0.32; P = .003) ( Figure, D and Table) . By July 2017, all samples from participants reporting nonprescribed opioid use were fentanyl-positive.
Discussion | Fentanyl-positive urine samples increased rapidly during a 5-month period while opiate-positive samples declined. In Vancouver, as elsewhere, 6 the initial phase of the opioid epidemic was associated with diverted pharmaceuticals. This changed as nonpharmaceutical fentanyl entered the market as a heroin additive. The low concordance between reported fentanyl use and detection is consistent with unawareness of exposure. In the early months, as fentanyl-positive samples rapidly increased in the participants, an increase in overdose calls to first responders occurred in the neighborhood, and fatal overdoses increased city-wide. Some amelioration occurred by July 2017 when fentanyl-positive urine samples were ubiquitous among participants reporting nonprescribed opioid use. Tolerance to the adverse effects of higher potency opioids may be developing among users, as some individuals report actively seeking fentanyl. 6 Fentanyl was detected in half of the participants in opioid agonist therapy programs in our study, which raises concern for increasing tolerance. 3 Our fentanyl assay demonstrates cross-reactivity with other fentanyl analogues. Rapid and specific tests for fentanyl and related analogues are urgently needed, along with innovative treatments.
